Established, emerging and future applications of FDG-PET/CT in the uterine cancer

K. Kitajima; K. Murakami; Y. Kaji; S. Sakamoto; K. Sugimura

doi:10.1016/j.crad.2010.07.012

Established, emerging and future applications of FDG-PET/CT in the uterine cancer

K. Kitajima, K. Murakami, Y. Kaji, S. Sakamoto, K. Sugimura

Department of Radiology

Research output: Contribution to journal › Review article › peer-review

26 Citations (Scopus)

Abstract

Integrated positron emission tomography/computed tomography (PET/CT) with 2-[¹⁸F]fluoro-2-deoxy-d-glucose (FDG) is a useful technique to acquire both glucose metabolic and anatomic imaging data using a single device in a single diagnostic session and has opened a new field in clinical oncologic imaging. FDG-PET/CT has been used successfully for the staging, optimization of treatment, re-staging, therapy monitoring, and prognostic prediction of uterine cervical cancer and endometrial cancer as well as various malignant tumours. The present review discusses the current role of FDG-PET/CT in the management of uterine cancer, discussing its usefulness and limitations in the imaging of these patients.

Original language	English
Pages (from-to)	297-307
Number of pages	11
Journal	Clinical Radiology
Volume	66
Issue number	4
DOIs	https://doi.org/10.1016/j.crad.2010.07.012
Publication status	Published - 2011 Apr

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.crad.2010.07.012

Cite this

@article{a447790713904846a9c182a66998ac58,

title = "Established, emerging and future applications of FDG-PET/CT in the uterine cancer",

abstract = "Integrated positron emission tomography/computed tomography (PET/CT) with 2-[18F]fluoro-2-deoxy-d-glucose (FDG) is a useful technique to acquire both glucose metabolic and anatomic imaging data using a single device in a single diagnostic session and has opened a new field in clinical oncologic imaging. FDG-PET/CT has been used successfully for the staging, optimization of treatment, re-staging, therapy monitoring, and prognostic prediction of uterine cervical cancer and endometrial cancer as well as various malignant tumours. The present review discusses the current role of FDG-PET/CT in the management of uterine cancer, discussing its usefulness and limitations in the imaging of these patients.",

author = "K. Kitajima and K. Murakami and Y. Kaji and S. Sakamoto and K. Sugimura",

year = "2011",

month = apr,

doi = "10.1016/j.crad.2010.07.012",

language = "English",

volume = "66",

pages = "297--307",

journal = "Clinical Radiology",

issn = "0009-9260",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Established, emerging and future applications of FDG-PET/CT in the uterine cancer

AU - Kitajima, K.

AU - Murakami, K.

AU - Kaji, Y.

AU - Sakamoto, S.

AU - Sugimura, K.

PY - 2011/4

Y1 - 2011/4

N2 - Integrated positron emission tomography/computed tomography (PET/CT) with 2-[18F]fluoro-2-deoxy-d-glucose (FDG) is a useful technique to acquire both glucose metabolic and anatomic imaging data using a single device in a single diagnostic session and has opened a new field in clinical oncologic imaging. FDG-PET/CT has been used successfully for the staging, optimization of treatment, re-staging, therapy monitoring, and prognostic prediction of uterine cervical cancer and endometrial cancer as well as various malignant tumours. The present review discusses the current role of FDG-PET/CT in the management of uterine cancer, discussing its usefulness and limitations in the imaging of these patients.

AB - Integrated positron emission tomography/computed tomography (PET/CT) with 2-[18F]fluoro-2-deoxy-d-glucose (FDG) is a useful technique to acquire both glucose metabolic and anatomic imaging data using a single device in a single diagnostic session and has opened a new field in clinical oncologic imaging. FDG-PET/CT has been used successfully for the staging, optimization of treatment, re-staging, therapy monitoring, and prognostic prediction of uterine cervical cancer and endometrial cancer as well as various malignant tumours. The present review discusses the current role of FDG-PET/CT in the management of uterine cancer, discussing its usefulness and limitations in the imaging of these patients.

UR - http://www.scopus.com/inward/record.url?scp=79952313806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952313806&partnerID=8YFLogxK

U2 - 10.1016/j.crad.2010.07.012

DO - 10.1016/j.crad.2010.07.012

M3 - Review article

C2 - 21356392

AN - SCOPUS:79952313806

SN - 0009-9260

VL - 66

SP - 297

EP - 307

JO - Clinical Radiology

JF - Clinical Radiology

IS - 4

ER -

Established, emerging and future applications of FDG-PET/CT in the uterine cancer

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this